RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Eli Lilly and Stocks 2024

Eli Lilly and Stocks

903.28 M

Eli Lilly and Dividend yield

0.61 %

Ticker

LLY

ISIN

US5324571083

WKN

858560

In 2024, Eli Lilly and had 903.28 M outstanding stocks, a 0% change from the 903.28 M stocks in the previous year.

The Eli Lilly and Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e0.9
2028e0.9
2027e0.9
2026e0.9
2025e0.9
2024e0.9
20230.9
20220.91
20210.91
20200.91
20190.94
20181.03
20171.05
20161.06
20151.07
20141.07
20131.09
20121.12
20111.11
20101.11
20091.1
20081.09
20071.09
20061.09
20051.09
20041.09

Eli Lilly and Aktienanalyse

What does Eli Lilly and do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Eli Lilly and's Shares Outstanding

Eli Lilly and's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Eli Lilly and’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Eli Lilly and’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Eli Lilly and’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Eli Lilly and Stock

How many stocks are there of Eli Lilly and?

The current number of stocks of Eli Lilly and is 903.28 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Eli Lilly and are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Eli Lilly and evolved in recent years?

The number of shares of Eli Lilly and has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Eli Lilly and as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Eli Lilly and?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Eli Lilly and pay?

Over the past 12 months, Eli Lilly and paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.61 %. For the coming 12 months, Eli Lilly and is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and?

The current dividend yield of Eli Lilly and is 0.61 %.

When does Eli Lilly and pay dividends?

Eli Lilly and pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Eli Lilly and?

Eli Lilly and paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.77 %.

In which sector is Eli Lilly and located?

Eli Lilly and is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and from 3/8/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 2/14/2024.

When did Eli Lilly and pay the last dividend?

The last dividend was paid out on 3/8/2024.

What was the dividend of Eli Lilly and in the year 2023?

In the year 2023, Eli Lilly and distributed 3.92 USD as dividends.

In which currency does Eli Lilly and pay out the dividend?

The dividends of Eli Lilly and are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eli Lilly and

Our stock analysis for Eli Lilly and Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.